Understanding how ezrin affects immune cells in the lungs
Role of Ezrin in Macrophages
This study is looking at how a protein called ezrin affects immune cells in the lungs, which are important for fighting infections and managing inflammation, especially in people with conditions like cystic fibrosis and asthma, to help find better ways to treat these lung diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10861005 on NIH RePORTER |
What this research studies
This research investigates the role of ezrin, a protein, in the function of macrophages, which are crucial immune cells in the lungs. It aims to understand how ezrin influences the behavior of these cells during infections and inflammation, particularly in conditions like cystic fibrosis and asthma. By studying the cellular changes that occur in macrophages when ezrin levels are altered, the research seeks to uncover new insights into how these immune cells respond to pathogens and regulate inflammation. This could lead to better understanding and potential treatments for chronic lung diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cystic fibrosis, asthma, or other chronic lung inflammatory diseases.
Not a fit: Patients with acute lung infections or those without chronic lung conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients with chronic lung diseases by enhancing our understanding of immune responses.
How similar studies have performed: Other research has shown that targeting immune cell functions can lead to significant advancements in treating chronic inflammatory diseases, suggesting this approach has potential.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Bruscia, Emanuela Marina — Yale University
- Study coordinator: Bruscia, Emanuela Marina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.